Rosty Raykov, a director at Fennec Pharmaceuticals Inc. (NASDAQ:FENC), a company currently valued at $187 million, has sold 10,000 common shares of the company, according to a recent SEC filing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results